The world of weight loss is changing, and some of the biggest names in sports are leading the charge! From Tom Brady's surprising move to Simone Biles' partnership, and Serena Williams' endorsement, star athletes are now openly promoting GLP-1 medications. This shift has sparked both excitement and debate. Let's dive in!
Recently, ex-NFL star Tom Brady was named chief wellness officer of a digital health platform that offers GLP-1 drugs, among other services. This move, along with endorsements from other high-profile athletes, marks a significant trend.
Since early 2024, the number of Americans using medications like Zepbound, Wegovy, and Ozempic for weight loss or diabetes control has more than doubled.
But here's where it gets controversial...
Dr. Peter Balazs, a hormone and weight loss specialist, believes that these endorsements can be a game-changer. He argues that they open the door for healthy discussions about the risks and benefits of these medications, potentially creating a safer environment for those considering them. Furthermore, these endorsements can encourage a healthier lifestyle.
Simone Biles, despite not using Mounjaro herself, has partnered with Eli Lilly. This collaboration, along with other similar partnerships, can help athletes navigate the transition from a rigorous training schedule to the possibility of weight gain after retirement.
Dr. Balazs also points out that promoting GLP-1 agonists alongside the principles athletes embody – like adequate protein intake and resistance training – is crucial to combatting sarcopenia, the loss of muscle mass, a potential side effect of these medications.
Serena Williams' partnership with a telehealth platform also plays a role in destigmatizing GLP-1 use.
Dr. Shiara Ortiz-Pujols, director of obesity medicine at Northwell’s Staten Island University Hospital, highlights that celebrity endorsements can normalize the conversation around GLP-1s. It also shows that even elite athletes can struggle with weight loss, making the issue more relatable.
Dr. Rachel Goldman, a clinical psychologist and obesity psychology advisor, adds that these endorsements can shift the focus from a moral perspective to a medical one.
And this is the part most people miss...
However, there are a few caveats. Dr. Ortiz-Pujols points out that athletes' jobs require intense training, optimal nutrition, and adequate sleep, which many people taking these medications may not have. There's also the misconception that these drugs could enhance performance, which she debunks by reminding us that athletes have access to personal trainers and chefs.
What do you think? Do you believe these endorsements are helpful, or do they oversimplify the complexities of weight loss? Share your thoughts in the comments below!
